BAM
CRL icon

Belpointe Asset Management’s Charles River Laboratories CRL Stock Holding History

Belpointe Asset Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-934
Closed -$189K – 1142
2023
Q1 		$189K Sell
934
-244
-21% -$55.3K 0.01% 971
2022
Q4 		$257K Buy
1,178
+94
+9% +$20.5K 0.02% 780
2022
Q3 		$213K Sell
1,084
-38
-3% -$8.2K 0.01% 804
2022
Q2 		$240K Sell
1,122
-117
-9% -$28.6K 0.02% 754
2022
Q1 		$352K Buy
1,239
+145
+13% +$44.7K 0.02% 662
2021
Q4 		$412K Buy
1,094
+15
+1% +$5.83K 0.03% 581
2021
Q3 		$445K Sell
1,079
-48
-4% -$19.9K 0.03% 543
2021
Q2 		$417K Buy
1,127
+20
+2% +$6.68K 0.03% 556
2021
Q1 		$321K Hold
1,107
– – 0.03% 575
2020
Q4 		$277K Buy
1,107
+5
+0.5% +$1.19K 0.02% 582
2020
Q3 		$250K Sell
1,102
-514
-32% -$107K 0.03% 493
2020
Q2 		$282K Sell
1,616
-153
-9% -$24.4K 0.04% 420
2020
Q1 		$223K Buy
+1,769
New +$265K 0.04% 404

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Belpointe Asset Management's CRL Position: Q2 2023 in Review

Belpointe Asset Management sold out of Charles River Laboratories (CRL) in Q2 2023, closing a stake of 934 shares — an estimated $189K sold.

Belpointe Asset Management first reported a position in CRL in Q1 2020 and held it in 13 quarters. The position peaked at $445K in Q3 2021. 612 funds tracked by Wall St. Rank hold CRL as of Q2 2023.

  • Belpointe Asset Management reported no remaining Charles River Laboratories position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 934 Charles River Laboratories shares in Q2 2023, an estimated $189K.
  • Belpointe Asset Management first reported a position in Charles River Laboratories in Q1 2020 and held it in 13 quarters.
  • Belpointe Asset Management's Charles River Laboratories position peaked at $445K in Q3 2021.
  • 612 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.